Clinical Trials on Appendix NET

Total 1925 results

Kantonsspital Winterthur KSW

Recruiting

Comparison of Laser Treatment With Clobetasol Therapy in Patients With Lichen Sclerosus

Lichen Sclerosus

Switzerland
Università Vita-Salute San Raffaele
IRCCS San Raffaele

Not yet recruiting

18F FES-PET/MRI for Tailoring Treatment of Luminal a and Lobular Breast Cancer (FESTA)

Breast Cancer Female | Lobular Breast Carcinoma | PET/MRI | Axillary Lymphadenopathy | Luminal a Breast Cancer
Clinical Exercise Physiology and Rehabilitation...

Not yet recruiting

Profiling the RCRSP Patient: a Pain Phenotype Classification Algorithm

Rotator Cuff Tear or Rupture, Not Specified as Traumatic | Rotator Cuff Tears | Rotator Cuff Tendinosis | Rotator Cuff Syndrome | Rotator Cuff Impingement
Zhongnan Hospital

Recruiting

Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma (FAPI-OSCC)

Oral Cancer | PET/CT | FAPI

China
Centre Leon Berard

Recruiting

Real Word European Registry of NTRK Fusions and Other Rare Actionable Fusions (TRacKING) (TRacKING)

Cancer | Cancer Metastatic | ALK Fusion Protein Expression | FGFR2 Gene Translocation | FGFR3 Gene Translocation | NTRK Family Gene Mutation | Gene Fusion | ROS1 Gene Translocation | NTRK Gene Fusion Overexpression | ATIC-ALK Fusion Protein Expression | BCR-FGFR1 Fusion Protein Expression | COL1A1-PDGFB Fusion... and other conditions

France, Denmark, Netherlands, Austria, Germany, Italy, United Kingdom, Czechia, Poland, Slovenia, Spain
Merck Sharp & Dohme LLC

Terminated

A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Advanced Solid Tumors (MK-8628-006)

Non-small Cell Lung Cancer (NSCLC) | Triple Negative Breast Cancer (TNBC) | NUT Midline Carcinoma (NMC) | Castration-resistant Prostate Cancer (CRPC)
Hadassah Medical Organization

Completed

Fractional / Pixel CO2 Laser Treatment of Vulvar Atrophy and Lichen Sclerosus

Vaginal Atrophy | Lichen Sclerosus

Israel
Jubilant Therapeutics Inc.

Recruiting

Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis

Myeloproliferative Neoplasms (MPN) | Essential Thrombocythemia (ET) | Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

Australia
University of Washington
National Cancer Institute (NCI); The Safeway Foundation

Completed

Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer

Digestive System Carcinoma | Gastric Carcinoma | Colon Carcinoma | Esophageal Carcinoma | Liver and Intrahepatic Bile Duct Carcinoma | Pancreatic Carcinoma | Rectal Carcinoma | Pancreatic Neuroendocrine Tumor | Anal Carcinoma | Malignant Digestive System Neoplasm | Appendix Carcinoma | Small Intestinal Carcinoma and other conditions

United States
University of Maryland, Baltimore

Withdrawn

Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas

Small Cell Lung Cancer (SCLC) | Neuroendocrine (NE) Tumors | Large Cell Neuroendocrine (NE) Tumors

United States
Maltepe University
The Scientific and Technological Research Council of Turkey; Psiko-Onkologlar... and other collaborators

Completed

Fear of Cancer Recurrence Therapy (FORT): Turkish Cultural Adaptation and Implementation Project

Anxiety | Self Efficacy | Depression Not Otherwise Specified | Fear of Cancer Recurrence | Intolerance of Uncertainty | Cancer Coping | Quality of Life (QOL)

Turkey (Türkiye)
Sun Yat-sen University

Completed

The Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate Cancer

Prostate Cancer Metastatic Disease | PET / CT

China
International Nature and Forest Therapy Alliance

Completed

Measuring the Effectiveness of Forest Therapy to Alleviate Stress Among International Students (FTIS-2024)

Stress | Stress, Psychological | Anxiety | Sleep Deprivation | Sleep Disorders, Circadian Rhythm | Stress Disorders | Lack of Physical Activity | Anxiety Depression (Mild or Not Persistent)

Australia
Emory University
National Cancer Institute (NCI); Pfizer; National Institutes of Health (NIH)

Completed

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis (ASPIRE)

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Metastatic Breast Carcinoma

United States
Sheba Medical Center

Completed

The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)

ADHD Predominantly Inattentive Type | Attention Deficit/Hyperactivity Disorder Combined Type | ADHD Predominantly Hyperactivity Type | ADHD-not Other Specified

Israel
Ada Health GmbH
Muhimbili University of Health and Allied Sciences

Active, not recruiting

Clinic Waiting Room-based Study of Swahili Language Artificial Intelligence-driven Symptom Assessments in Tanzanian Primary Health Care Facilities (AFYA)

Neurological Conditions | Mental Health Conditions | Abdominal Pain/Gastrointestinal Issues | Lower Respiratory System Conditions | Upper Respiratory System Conditions | Ophthalmology Conditions | Orthopedic Conditions | Cardiovascular System Conditions | Genitourinary System Conditions | ENT Conditions | Dermatology Conditions and other conditions

Tanzania
OHSU Knight Cancer Institute
Oregon Health and Science University; Prospect Creek Foundation

Completed

Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma

United States
Prescient Therapeutics, Ltd.
National Cancer Institute (NCI)

Terminated

PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Breast Adenocarcinoma

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Terminated

Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7 | MET Positive

United States
Curis, Inc.

Completed

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

High-grade Serous Ovarian Cancer | Solid Tumors | Triple-Negative Breast Cancer | NUT Midline Carcinoma

United States
Stanford University
Avadel

Recruiting

Extended-release Sodium Oxybate in Children

Narcolepsy Type 1 (NT 1)

United States
University of Texas Southwestern Medical Center
Dermatology Foundation

Completed

Characterizing the Microbiome in Postmenopausal Women With Vulvar Lichen Sclerosus

Vulvar Lichen Sclerosus

United States
Medstar Health Research Institute

Completed

Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus (CuRLS)

Vulvar Lichen Sclerosus

United States
Center for Vulvovaginal Disorders
Gynecologic Cancer Research Foundation; El. En. SpA

Completed

MonaLisa Touch Laser for the Treatment of Vulvar Lichen Sclerosus

Lichen Sclerosus

United States
Instituto de Investigacion Sanitaria La Fe

Completed

Evaluation of Vulvar Lichen Sclerosus Treatment Using Adipose Tissue Associated With Autologous Platelet-rich Plasma.

Vulvar Lichen Sclerosus

Spain
Dermtreat
Larix A/S

Completed

The Comfort and Adherence of Rivelin® Plain Patches in Vulva Lichen Sclerosus Patients

Vulvar Lichen Sclerosus

Denmark
Deana Funaro
Astellas Pharma Inc

Completed

Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen Sclerosus

Vulvar Lichen Sclerosus

Canada
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors

Recurrent Childhood Medulloblastoma | Recurrent Childhood Ependymoma | Childhood Atypical Teratoid/Rhabdoid Tumor | Ependymoma | Childhood Craniopharyngioma | Childhood Grade I Meningioma | Childhood Grade II Meningioma | Childhood Grade III Meningioma | Childhood Infratentorial Ependymoma | Childhood... and other conditions

United States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
M.D. Anderson Cancer Center

Completed

Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas

Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides | Refractory Mycosis Fungoides | Recurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma | Refractory Anaplastic Large Cell Lymphoma | Recurrent Anaplastic Large Cell Lymphoma and other conditions

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes

Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Cervical Small Cell Carcinoma | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer

United States
University College, London

Recruiting

Determining the Mechanisms of Loss of CAR T Cell Persistence (CARPERS)

Acute Lymphoblastic Leukemia, Pediatric | Acute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia, Adult | Acute Lymphoblastic Leukemia With Failed Remission | Acute Lymphoblastic Leukemia Not Having Achieved Remission

United Kingdom
Outlook Therapeutics, Inc.

Active, not recruiting

A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders (NORSE SEVEN)

Age-Related Macular Degeneration | Diabetic Macular Edema | Wet Macular Degeneration | Neovascular Age-related Macular Degeneration | BRVO - Branch Retinal Vein Occlusion

United States
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery

Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu Negative | Estrogen Receptor and/or Progesterone Receptor Positive

United States
Kamada, Ltd.

Completed

Phase II Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes

New Onset Type-1 Diabetes

Israel
Novartis Pharmaceuticals

Terminated

Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors

Pancreatic Neuroendocrine Tumors (pNET)

United Kingdom, Spain, Netherlands, Italy, Russian Federation, France, Switzerland, United States
National Cancer Institute (NCI)

Terminated

RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Male Breast Carcinoma

United States
National Cancer Institute (NCI)

Terminated

RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By Surgery

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma

United States
Ankara University

Completed

Role of Cord Blood Hormones and Epinephrine in the Development of Transient Tachypnea of the Newborn

Wet Lung
Sunnybrook Health Sciences Centre

Recruiting

Life Following Excision of Neuroendocrine Tumors (LIFENETS)

Neuroendocrine (NE) Tumors | Neuroendocrine Tumor GEP Grade 1-3

Canada
Takeda

Terminated

A Study of TAK-994 in Adults With Narcolepsy

Narcolepsy Type 1 (NT 1)

United States, Italy, Finland, Canada, Hungary, Czechia, France, Japan, Korea, Republic of, Spain
Center for Vulvovaginal Disorders
Novartis

Completed

Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus

Lichen Sclerosus

United States
Ruhr University of Bochum

Completed

Topical 0.05% Clobetasol Propionate in Vaseline Versus UVA-1 Phototherapy in Vulvar Lichen Sclerosus

Vulvar Lichen Sclerosus

Germany
The Guenther Dermatology Research Centre
Biogen

Completed

Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis

Psoriasis | Palmoplantaris Pustulosis | Pustulosis of Palms and Soles | Pustular Psoriasis of Palms and Soles | Pustulosis Palmaris et Plantaris

Canada
The Children's Hospital of Zhejiang University...

Not yet recruiting

NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL

Minimal Residual Disease | Pediatric | B Cell Precursor Acute Lymphoblastic Leukemia | Next Generation Sequencing (NGS)
Texas Cardiac Arrhythmia Research Foundation

Recruiting

Natural History of COVID-19-Related Atrial Fibrillation (unCOVer-AF)

COVID-19 | Atrial Fibrillation New Onset

Italy, United States, Belgium
Hunan Province Tumor Hospital

Recruiting

Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation (PIKACHU)

Non Small Cell Lung Cancer | ALK Gene Mutation | MET Gene Mutation | EGFR Gene Mutation | ROS1 Gene Mutation

China
NRG Oncology
National Cancer Institute (NCI)

Active, not recruiting

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

Stage IIIA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Breast Adenocarcinoma

United States, Canada
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma

Medulloblastoma | Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor | Anaplastic Medulloblastoma | Supratentorial Embryonal Tumor, Not Otherwise Specified

United States, Canada, Australia, Puerto Rico
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer

Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Metastatic Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Androgen Receptor Positive

United States
Northwestern University
National Cancer Institute (NCI); Amgen

Terminated

Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells

Stage IV Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Breast Carcinoma Metastatic in the Bone | Circulating Tumor Cell Count

United States

Clinical Trials on Appendix NET

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations